Anti Obesity Prescription Drugs Market Size And Share

  • Report Code : TIPRE00020942
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Anti-Obesity Prescription Drugs Market Size - Trends by 2031

Buy Now

Anti-Obesity Prescription Drugs Market Report Anti-Obesity Prescription Drugs Market Scope and Analysis Anti-Obesity Prescription Drugs Market Size and Share

Anti-Obesity Prescription Drugs Market Report Analysis

Anti-Obesity Prescription Drugs Market

  • CAGR (2025 - 2031)
    26%
  • Market Size 2024
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • BRISTOL MYERS SQUIBB CO
  • TAKEDA PHARMACEUTICAL
  • EISAI COMPANY
  • GLAXOSMITHKLINE PLC
  • PFIZER INC
  • SHIONOGI USA INC
  • VIVUS INC
  • ZAFGEN INC
  • NORGINE BV

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

By Mechanism of Action
  • Peripherally Acting Drugs
  • Centrally Acting Drugs
By Drug Class
  • Bupropion and Naltrexone
  • Orlistat
  • Lorcaserin
  • Phentermine and Topiramate
  • Liraglutide
By Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy